{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:00:54Z","timestamp":1762898454847},"reference-count":102,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The cure rate of acute lymphoblastic leukaemia (ALL) in adults remains unsatisfactory. The remarkable progress in childhood ALL has not been replicated in adult ALL and approximately two thirds of patients younger than 60\u2003years, and more than 90% of those over 60\u2003years, are expected to succumb to their disease. Over 80% of adults can achieve a complete remission; however, the majority of such patients relapse. Nevertheless, significant developments have occurred over the past decade. Prognostic factors have been more clearly defined, moving cytogenetics and molecular determinants forefront, much like acute myeloid leukaemia. Studies of postremission therapy have included prospective evaluation of allogeneic transplantation in areas not previously evaluated, i.e. patients with standard risk. Most importantly, the advent of imatinib mesylate has changed the outlook for adults with Ph\u2010positive ALL. Much work needs to be done to further improve chemotherapy treatment and reduce the toxicity of transplants.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07513.x","type":"journal-article","created":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T20:14:14Z","timestamp":1228162454000},"page":"468-483","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Optimal management of adults with ALL"],"prefix":"10.1111","volume":"144","author":[{"given":"Jacob M.","family":"Rowe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.863"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544040-00003"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.1986"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.52"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705889"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.1580"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.5253"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200091"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cppeds.2005.02.001"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.053"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403538"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-132837"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2708"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2006.05.007"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.6.2091.bloodjournal8662091"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0006"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-056754"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404065"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0704"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(03)00149-6"},{"key":"e_1_2_11_22_1","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood-2006-07-035006","article-title":"Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55\u2003years or younger with newly diagnosed acute lymphoblastic leukemia","volume":"109","author":"Douer D.","year":"2007","journal-title":"Blood"},{"key":"e_1_2_11_23_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1182\/blood.V110.11.8.8","article-title":"Does Imatinib Change the Outcome in Philapdelphia Chromosome Positive Acute Lymphoblastic Leukaemia in Adults? Data from the UKALLXII\/ECOG2993 Study","volume":"110","author":"Fielding A.K.","year":"2007","journal-title":"Blood"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.10.1990"},{"key":"e_1_2_11_25_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.6004\/jnccn.2007.0020","article-title":"Growth factors in leukemia","volume":"5","author":"Frankfurt O.","year":"2007","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2006.1.133"},{"key":"e_1_2_11_27_1","first-page":"802a","article-title":"Intensification of induction and consolidation improves only subgroups of adult ALL: analysis of 1200 patients in GMALL study 05\/93","volume":"98","author":"Gokbuget N.","year":"2001","journal-title":"Blood"},{"key":"e_1_2_11_28_1","article-title":"The outcome of 267 Philadelphia\u2010positive adults in the International UKALL XII\/ ECOG E2993 study. Final analysis and the role of allogeneic transplant in those under 50\u2003years","volume":"104","author":"Goldstone A.H.","year":"2003","journal-title":"Blood"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116582"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-149088"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705769"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03685.x"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22189"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704776"},{"key":"e_1_2_11_35_1","first-page":"533","volume-title":"ASCO Education Book","author":"Hoelzer D.","year":"2005"},{"key":"e_1_2_11_36_1","doi-asserted-by":"crossref","first-page":"518a","DOI":"10.1182\/blood.V110.11.518.518","article-title":"High Survival Rate in Adult Burkitt\u2019s Lymphoma\/Leukemia and Diffuse Large B\u2010Cell Lymphoma with Mediastinal Involvement","volume":"110","author":"Hoelzer D.","year":"2007","journal-title":"Blood"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07185.x"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3560"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-043646"},{"key":"e_1_2_11_40_1","first-page":"468","article-title":"Drug evaluation: Nilotinib \u2013 a novel Bcr\u2010Abl tyrosine kinase inhibitor for the treatment of chronic myelocytic leukemia and beyond","volume":"10","author":"Jabbour E.","year":"2007","journal-title":"IDrugs"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198411083111905"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702706"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.8554"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.3.547"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20668"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.07.130"},{"key":"e_1_2_11_47_1","first-page":"809","article-title":"Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non\u2010Hodgkin\u2019s lymphoma for patients <or=50\u2003years old in first complete remission: results of the EORTC ALL\u20103 trial","volume":"89","author":"Labar B.","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-011908"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-143115"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2006.01.007"},{"key":"e_1_2_11_51_1","first-page":"1556","article-title":"A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111","volume":"92","author":"Larson R.A.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4666"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403886"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3785"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.082"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0294"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.13.821"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.07.116"},{"key":"e_1_2_11_59_1","article-title":"An integrated molecular\u2010cytogenetic classification is highly predictive of outcome in adult acute lymphoblastic leukemia (ALL): analysis of 395 cases enrolled in the GIMEMA 0496 trial","volume":"98","author":"Mancini M.","year":"2001","journal-title":"Blood"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-128918"},{"key":"e_1_2_11_61_1","first-page":"555","article-title":"Allogeneic hematopoietic stem cell transplantation with reduced\u2010intensity conditioning in acute lymphoblastic leukemia: a feasibility study","volume":"88","author":"Martino R.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11960"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-051912"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.4.1094"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1901"},{"key":"e_1_2_11_66_1","first-page":"535","article-title":"L\u2010Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia","volume":"37","author":"Ortega J.A.","year":"1977","journal-title":"Cancer Research"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22631"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4864"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402006"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052603"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60457-2"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116186"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20776"},{"key":"e_1_2_11_74_1","first-page":"1346","article-title":"Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post\u2010remission treatment for adult patients with high\u2010risk acute lymphoblastic leukemia. Results of the PETHEMA ALL\u201093 trial","volume":"90","author":"Ribera J.M.","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2008.07.002"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1623"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.116"},{"key":"e_1_2_11_78_1","first-page":"76","article-title":"Acute lymphoblastic leukemia in adolescents between 10 and 19\u2003years of age in Denmark \u2013 secondary publication","volume":"53","author":"Schroder H.","year":"2006","journal-title":"Danish Medical Bulletin"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.12.2580"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099480"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1211"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.12.374"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-130237"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.6.1720.1720"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404603"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402526"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404824"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70190-8"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.050"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2958"},{"key":"e_1_2_11_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21776"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21595"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21901"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-052746"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04925.x"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2184.2007.00426.x"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4386"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197905103001902"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-09-045351"},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21932"},{"key":"e_1_2_11_101_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.2177"},{"key":"e_1_2_11_102_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-6-199509150-00006"},{"key":"e_1_2_11_103_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-09-045369"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07513.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07513.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T22:35:39Z","timestamp":1695940539000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07513.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07513.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07513.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,21]]},"assertion":[{"value":"2009-01-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}